CPHI North America
Booth: 401
April 25th to 27th, 2023
Pennsylvania Convention Center, Philadelphia
The Aurigene expertise
Aurigene Pharmaceutical Services Limited is an integrated partner for global pharma companies. It covers the entire value chain for new therapeutics, from drug discovery, clinical research, and development to manufacturing APIs and formulation at commercial scales. It has development laboratories from discovery to clinical phase III for New Chemical and Biological Entities (NCEs/NBEs) and cGMP manufacturing facilities in the UK, Mexico, USA, and India. The technology platforms include cytotoxic APIs, carbohydrates, steroids, PEG derivatives, prostaglandins, peptides, and oligonucleotides. Large molecule discovery services include ADC, MAB, mRNA, CART-T as well as development services in MAB and protein therapeutics.
About CPHI North America
CPHI North America (CPHI NA) is one of the most significant international events in the pharmaceutical industry, held annually in North America.
In 2023, CPHI NA is set to take place as a hybrid event, combining both in-person and online experiences. The three-day event will provide attendees with the opportunity to experience the best of both worlds by combining the traditional aspects of an in-person event with innovative and interactive online features. With this hybrid model, participants can benefit from a wider range of networking and learning opportunities, regardless of their location. Be sure to mark your calendars for CPHI NA 2023, where you can connect with industry professionals, explore the latest trends and technologies.
Why Aurigene Pharmaceutical Services?
Infrastructure 8 US FDA plants, 2 R&D centers and AAALAC animal vivarium
One Stop Shop Discovery to manufacturing
Science Strong technology platforms with niche/ sensitive/ complex chemistry expertise
Digitally Enabled Systems ELN, e-BPRs, MES, SAP etc. are fully enabled at R&D/cGMP site
ESG Commitment to highest standards of Environment, Social and Governance
Meet our Expert Attendees
Jay Ezhuthachan
BD Head - North America
Anthony McLellan
AVP - Business Development
Baburaj Krishnan
Head CDMO (DS)
Services we Offer
Chemical Development Services
Aurigene Pharmaceutical Services provides a wide range of pharmaceutical drug development services for pre-clinical and clinical trials I, II and III wherein we synthesize New Chemical Entity (NCE) from few grams for efficacy and toxicology studies to multi-kilogram for clinical trial studies. These can be offered from GLP compliant and cGMP environment to meet client requirements.
Formulation Development Services
Aurigene Pharmaceutical Services offers end-to-end formulation development services ranging from early development to clinical supplies for new chemical entities for the pharmaceutical, nutraceutical & animal healthcare industry along with life cycle extension of the products. We have the expertise along with the state-of-the-art infrastructure and diverse experience to develop formulations for your pre-clinical and clinical needs to support oral, topical & parenteral administration. Our formulation development effort revolves around developing the best formulation for your compound, focusing on the desired bioavailability and optimal stability of your drug product.
Starting with comprehensive pre-formulation services Aurigene Pharmaceutical Services helps its clients to determine optimal dosage forms they can use for pre-clinical or clinical applications.
Manufacturing Services
Aurigene has access to the manufacturing facilities of Dr. Reddy’s and a network of strategic business partners. Our pharmaceutical drug manufacturing services offer a wide range of manufacturing services from a few kilos to multi tons of cGMP manufacturing of Key Starting Material (KSM) / Registered Starting Materials (RSM), advanced intermediates, APIs and finished formulations. We have manufacturing options across the globe, with our facilities located in India, the UK, Mexico and the US. With a strong legacy of supporting New Chemical Entity (NCE) manufacturing, drug substances and drug products commercial manufacturing, we are able to cater to Pharma, Specialty, Nutraceutical and Animal Health companies.
CDMO Facility Locations
Hyderabad:
Aurigene Pharmaceutical Services Limited,
Bollaram Road, Miyapur, Jaya Prakash Narayan Nagar, Miyapur, Telangana 500049
Bangalore:
Aurigene Pharmaceutical Services Limited,
39-40 Hosur Road KIADB Industrial Area, Joggers Ln, Phase 2, Electronic City, Bengaluru, Karnataka 560100
Visakhapatnam:
APIIC Industrial Estate, Pydibhimavarama (village), Srikakulam district, Andhra Pradesh, India.
UK: API/ RSM Manufacturing Plant
Steanard Ln, Mirfield W14 8HZ, United Kingdom
Mexico:
C.P, Carretera Federal Cuernavaca-Cuautla Km. 4.5 Colonia CIVAC Jiutepec, 62578 Cuernavaca, Mor. Mexico
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market